Target intelligence / Profile preview

Virus-infected or malignant host cell

Molecular classification
Other
01

Overview

"Virus-infected or malignant host cell" is not a specific molecular target but rather a broad description of cells that have either been infected by viruses or have undergone malignant transformation (become cancerous). These cells are characterized by the presence of foreign genetic material—either viral genomes in the case of infection[3][4], or oncogenic mutations in the case of malignancy. Both types can evade normal immune surveillance and may display altered surface markers, metabolic changes, and abnormal growth properties. While many therapies aim to selectively target these abnormal cells (for example, antiviral drugs targeting infected cells or chemotherapies targeting cancer cells), "virus-infected or malignant host cell" itself does not refer to a single molecule, receptor, enzyme, transporter, or other canonical drug target class. Instead, it is an umbrella term encompassing diverse cellular states resulting from infection[3][4] or oncogenic processes. Because this entry refers to a heterogeneous population rather than a defined molecular entity with specific structure and function—and lacks standard nomenclature—it should be considered incorrect as a canonical therapeutic target according to standard conventions.

Other names
Infected cellMalignant cellVirus-infected cellCancerous cell
02

Biological functions

Host for viral replicationHost for malignant transformationImmune evasionCell proliferation (in malignancy)Apoptosis resistance (in malignancy)
03

Disease associations

InfectionCancer

Beyond the preview

Go deeper on Virus-infected or malignant host cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virus-infected or malignant host cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call